Literature DB >> 12009501

Neutrophils CD11b and fibroblasts PGE(2) are elevated in Alzheimer's disease.

Carla Scali1, Costanza Prosperi, Laura Bracco, Carolina Piccini, Roberto Baronti, Andrea Ginestroni, Sandro Sorbi, Giancarlo Pepeu, Fiorella Casamenti.   

Abstract

To evaluate whether inflammation-like mechanisms present in the brain of Alzheimer's disease (AD) patients are reflected in the periphery, the expression of CD11b in peripheral blood neutrophils and the expression and activity of inflammatory markers in cultured skin fibroblasts were examined. We found significantly higher levels of CD11b in neutrophils from sporadic AD patients than in controls and this elevation was positively correlated with disease severity and progression rate of mental decline. Cultured skin fibroblasts from familial (FAD) and sporadic AD patients and from controls were immunopositive for both isoforms of cyclooxygenase with no differences between groups. In unstimulated culture, the production of prostaglandin-E2 in the medium was significantly higher in fibroblasts from sporadic AD and FAD patients than in controls, and this elevation was reverted by the addition of 25 microM of ibuprofen. Our findings provide further evidence of the presence of inflammatory and immuno-related markers in the periphery of AD patients and support those studies indicating the beneficial effects of anti-inflammatory therapy in AD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12009501     DOI: 10.1016/s0197-4580(01)00346-3

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  15 in total

1.  Neuroimmunoendocrine regulation of the prion protein in neutrophils.

Authors:  Rafael M Mariante; Alberto Nóbrega; Rodrigo A P Martins; Rômulo B Areal; Maria Bellio; Rafael Linden
Journal:  J Biol Chem       Date:  2012-08-21       Impact factor: 5.157

2.  SMN deficiency negatively impacts red pulp macrophages and spleen development in mouse models of spinal muscular atrophy.

Authors:  Marie-Therese Khairallah; Jacob Astroski; Sarah K Custer; Elliot J Androphy; Craig L Franklin; Christian L Lorson
Journal:  Hum Mol Genet       Date:  2017-03-01       Impact factor: 6.150

3.  A roadmap for investigating the role of the prion protein in depression associated with neurodegenerative disease.

Authors:  Danielle Beckman; Rafael Linden
Journal:  Prion       Date:  2016-03-03       Impact factor: 3.931

4.  Immunophenotypes in the circulation of patients with mild cognitive impairment.

Authors:  Shino Magaki; Steven M Yellon; Claudius Mueller; Wolff M Kirsch
Journal:  J Psychiatr Res       Date:  2007-02-23       Impact factor: 4.791

Review 5.  Inflammation and clinical presentation in neurodegenerative disease: a volatile relationship.

Authors:  Brianne Magouirk Bettcher; Joel H Kramer
Journal:  Neurocase       Date:  2012-04-19       Impact factor: 0.881

Review 6.  Can peripheral leukocytes be used as Alzheimer's disease biomarkers?

Authors:  Kavon Rezai-Zadeh; David Gate; Christine A Szekely; Terrence Town
Journal:  Expert Rev Neurother       Date:  2009-11       Impact factor: 4.618

7.  Proteomic analysis of peripheral leukocytes in Alzheimer's disease patients treated with divalproex sodium.

Authors:  Timothy R Mhyre; Rebekah Loy; Pierre N Tariot; Louis A Profenno; Kathleen A Maguire-Zeiss; Dabao Zhang; Paul D Coleman; Howard J Federoff
Journal:  Neurobiol Aging       Date:  2007-05-22       Impact factor: 4.673

Review 8.  Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.

Authors:  A J Larner; M Doran
Journal:  J Neurol       Date:  2005-11-04       Impact factor: 6.682

Review 9.  Identifying Therapeutic Targets for Spinocerebellar Ataxia Type 3/Machado-Joseph Disease through Integration of Pathological Biomarkers and Therapeutic Strategies.

Authors:  Yu-Shuan Chen; Zhen-Xiang Hong; Shinn-Zong Lin; Horng-Jyh Harn
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923

10.  Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice.

Authors:  Rebecca Banerjee; R Lee Mosley; Ashley D Reynolds; Alok Dhar; Vernice Jackson-Lewis; Paul H Gordon; Serge Przedborski; Howard E Gendelman
Journal:  PLoS One       Date:  2008-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.